Italy· 043534015
NUWIQ*1 flaconcino EV 250 Unita' Internazionali + 1 siringa solv 2,5 ml
A blood coagulation factors product containing simoctocog alfa, registered in Italy by OCTAPHARMA AB, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Simoctocog alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC B02BD (blood coagulation factors), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Simoctocog alfa · ATC B02BD
4 / 19 countries
- Ireland
- Italyprice
- Netherlands
- Norwayprice
The record
At a glance
- Active substance
- Simoctocog Alfa
- Manufacturer
- OCTAPHARMA AB
- Country
- Italy (IT)
- ATC code
- B02BD
- ATC class
- Blood coagulation factors
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043534015NUWIQ*1 flaconcino EV 250 Unita' Internazionali + 1 siringa solv 2,5 mlEUR 268.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Simoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNuwiq 1000 IUOctapharma
- FinlandNuwiqOctapharma AB
- IrelandNuwiq 1000 IU powder and solvent for solution for injectionOctapharma AB
- NetherlandsNuwiq 1000 IE poeder en oplosmiddel voor oplossing voor injectieOctapharma AB
- PolandNuwiqOctapharma AB
- FranceNUWIQ 1000 UI, poudre et solvant pour solution injectableOCTAPHARMA (SUEDE)
- IcelandNuwiqOctapharma AB
- CzechiaNUWIQOctapharma AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nuwiq
- Liechtenstein · Nuwiq
- Norway · Nuwiq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1be532a4-2602-4a11-b4e0-41ed7a7f8cae GET /v1/drugs/1be532a4-2602-4a11-b4e0-41ed7a7f8cae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 268.19,
"source": "aifa",
"currency": "EUR",
"strength": "SIMOCTOCOG ALFA 250UI 2,5ML 1 UNITA' USO PARENTERALE",
"substance": "Simoctocog Alfa",
"equivalence_group": "LMU",
"transparency_flag": null
}See everything about simoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.